Ardsley Advisory Partners LP Roivant Sciences Ltd. Transaction History

Ardsley Advisory Partners LP

  • $564 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$8.38 - $11.58 $637,299 - $880,659
76,050 Added 16.9%
526,050 $5.91 Million
Q3 2023

Nov 14, 2023
SELL
$9.76 - $13.19 $1.02 Million - $1.37 Million
-104,000 Reduced 18.77%
450,000 $5.26 Million
Q2 2023

Aug 14, 2023
BUY
$7.09 - $10.08 $3.93 Million - $5.58 Million
554,000 New
554,000 $5.58 Million

Others Institutions Holding ROIV

# of Institutions
311
Shares Held
508M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email